Drug intelligence / Profile preview

total alkaloids of Alstonia scholaris leaf capsules

Development stage
Unknown
Lead developer
Kunming Institute of Botany
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

total alkaloids of Alstonia scholaris leaf capsules is an investigational botanical drug (natural drug class 5 in China) developed by the Kunming Institute of Botany, Chinese Academy of Sciences, in collaboration with the Yunnan Institute of Materia Medica. Derived from the leaves of *Alstonia scholaris* (L.) R. Br. (commonly known as the blackboard tree or "Dengtaiye" in traditional Dai medicine), this formulation is enriched with monoterpenoid indole alkaloids (such as picrinine) that exhibit anti-inflammatory, antitussive, anti-asthmatic, and expectorant properties. Preclinical studies suggest its mechanism of action involves the activation of beta-2 adrenergic receptors and the inhibition of the nuclear factor-kappaB (NF-kappaB) signaling pathway, thereby reducing airway inflammation and hyperresponsiveness. It is currently in Phase IIb clinical development in China for the treatment of postinfectious cough (PIC) with a traditional Chinese medicine pattern of wind-heat stagnation in the lung.

Other names
Alstonia scholaris alkaloid capsuletotal alkaloids of Alstonia scholaris leavestotal alkaloids of Alstonia scholaris leaftotal indole alkaloids from Alstonia scholaris灯台叶总生物碱胶囊
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADRB2 (β2)ALOX12 (Arachidonate 12-lipoxygenase, 12S type)

Beyond the preview

Go deeper on total alkaloids of Alstonia scholaris leaf capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on total alkaloids of Alstonia scholaris leaf capsules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call